Last reviewed · How we verify

NCT05901181

The Effect of Laughter Yoga on Self-Care, Quality of Life and Stress Level in Menopause

Status unknown NA Last updated 13 June 2023
What this trial tests

NA trial testing Laughter Yoga in Laughter in 60 participants. Status unknown.

Timeline
30 June 2023
Primary endpoint
16 February 2024
16 February 2024

Quick facts

Lead sponsorEastern Mediterranean University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment60
Start date30 June 2023
Primary completion16 February 2024
Estimated completion16 February 2024
Sites1 location across Cyprus

Drugs / interventions tested

Conditions studied

Sponsor

Eastern Mediterranean University

Who can join

Adults 45 to 65, female only, with Laughter or Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In order to evaluate the effects of laughter yoga on the quality of life, stress, cortisol, blood pressure levels and conscious self-care powers of menopausal women, it will be performed in two stages (the first stage is qualitative and the second stage is randomized controlled) on menopausal women in the TRNC Famagusta region.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Laughter Yoga

Trials testing the same drug.

Other recruiting trials for Laughter

Currently open trials in the same condition.

Other Eastern Mediterranean University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05901181.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing